2020
DOI: 10.1096/fj.202000100r
|View full text |Cite
|
Sign up to set email alerts
|

The intramolecular agonist is obligate for activation of glycoprotein hormone receptors

Abstract: This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
3

Relationship

3
6

Authors

Journals

citations
Cited by 19 publications
(11 citation statements)
references
References 79 publications
2
9
0
Order By: Relevance
“…In the case of GPR133, where the uncleavable H543R mutant demonstrates 60% of the basal activity of the WT cleaved receptor, it is possible that the Stachel sequence is already prebound in the agonist-binding site of the CTF and cleavage allows full isomerization to the active state. Such a model would be consistent with isomerization properties of other GPCRs with tethered agonists ( 33 , 34 , 35 ).…”
Section: Discussionsupporting
confidence: 66%
“…In the case of GPR133, where the uncleavable H543R mutant demonstrates 60% of the basal activity of the WT cleaved receptor, it is possible that the Stachel sequence is already prebound in the agonist-binding site of the CTF and cleavage allows full isomerization to the active state. Such a model would be consistent with isomerization properties of other GPCRs with tethered agonists ( 33 , 34 , 35 ).…”
Section: Discussionsupporting
confidence: 66%
“…In the case of GPR133, where the uncleavable H543R mutant demonstrates 60% of the basal activity of the wild-type cleaved receptor, it is possible that the Stachel sequence is already prebound in the agonist binding site of the CTF and cleavage allows full isomerization to the active state. Such a model would be consistent with isomerization properties of other GPCRs with tethered agonists (Bruser et al, 2016; Schoneberg et al, 2016; Schulze et al, 2020).…”
Section: Discussionsupporting
confidence: 64%
“…3e). Previous mutagenesis to other hydrophobic residues (T, L) at this site has been shown to increase basal and agonist-mediated cAMP accumulation 40 . Thus, we investigated whether lipid occupancy in this transmembrane pocket is important in activation of the TSHR.…”
Section: Agonist M22 Autoantibody Mimics Tsh To Activate Tshrmentioning
confidence: 99%